 protocol safe administration debrisoquine biochemical epidemiologic research protocols hospitalized patients ability antihypertensive drug debrisoquine genetic risk factor primary carcinomas lung hypothesis metabolism drug case control study subjects ability debrisoquine test dose drug collection urine sample laboratory analysis following groups extensive intermediate poor metabolizers Poor metabolizers population unable drug group risk deleterious effects medication protocol patient education blood pressure monitoring medication group patients cancer poor metabolizers small decrease systolic diastolic blood pressure significant hypotensive episodes clinical sequelae groups data debrisoquine controlled clinical setting useful characterization lung cancer patients biochemical epidemiology studies